The story of Viagra and its influence on the healthcare landscape presents a intriguing question for investors . Initially a massive drug, generics have significantly chipped away at its market presence , https://elodieeyuf540847.smblogsites.com/41786267/the-blue-pill-and-big-pharma-a-risky-opportunity